Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-14
1991-12-03
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514471, A61K 3134, A61K 31415
Patent
active
050701010
ABSTRACT:
Persons suffering from negative symptoms of schizophrenia can be successfy treated using a histamine H.sub.2 -antagonist which crosses the blood-brain barrier so as to interact with histamine-H.sub.2 receptors in the brain. A preferred H.sub.2 -antagonist is famotidine. The H.sub.2 -antagonist may be used alone in patients who are relatively free of positive symptoms or it may be used in combination with known neuroleptics. A pharmaceutical composition containing both an H.sub.2 -antagonist and a neuroleptic is part of the present invention.
Friedman Stanley J.
Mount Sinai School of Medicine of the City University of New Yor
LandOfFree
Method and pharmaceutical composition for the treatment of schiz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and pharmaceutical composition for the treatment of schiz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical composition for the treatment of schiz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1697240